可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 秦永文,穆瑞斌. 室间隔缺损封堵器的研制和临床应用进展[J]. 心脏杂志,2004,16(专刊):S4-S7.
[2] 张玉顺,李寰,刘建平. 膜/周部室间隔缺损介入治疗并发症分析和防治[J]. 心脏杂志,2004,16(专刊):S40-S43.
[3] 臧益民,王一斌. 室间隔缺损介入治疗术后传导阻滞发生机制探索[J]. 心脏杂志,2004,16(专刊):S29-S30.
[4] Bronicki RA, Backer CL, Baden HP, et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children[J]. Ann Thorac Surg,2000,69(5):1490-1495.
[5] Pees C, Haas NA., von der Beek J, et al. Cardiac troponin I is increased after interventional closure of atrial septal defects[J]. Cathet and Cardiovasc Interv,2003,58 (1):124- 129.
[6] 秦玉明,王大为,杨世伟,等. 心肌肌钙蛋白在小儿先天性心脏病介入治疗中的变化[J]. 心脏杂志,2005,17(专刊):S66-S69.
[7] Li JJ, Fang CH, Jiang H, et al. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis[J]. Clin Chim Acta, 2004,350(1-2):115-121.
[8] Saadeddin SM, Habbab MA.Percutaneous coronary intervention in the context of systemic inflammation: more injury and worse outcome[J]. Med Sci Monit,2003,9(8):193-197.
[9] 徐彤彤,于方.冠心病患者血清C反应蛋白水平的变化及其临床意义[J]. 心脏杂志,2004,16(5):443-445.